MITF and neoplasm: Additionally, the immunohistochemical analysis of MITF expression on serial sections of the same samples revealed higher immunolabelling for this melanocyte differentiation marker mainly on areas characterized by a strong reactivity for β-catenin, further confirming that the phenotypical features highlighted in vitro match with the original tumour (Supplementary Figure 6).